These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26319706)

  • 21. Cardiac magnetic resonance imaging for myocarditis and nonischemic cardiomyopathies.
    Wassmuth R
    Minerva Cardioangiol; 2009 Aug; 57(4):511-20. PubMed ID: 19763072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects.
    Krombach GA; Hahn C; Tomars M; Buecker A; Grawe A; Günther RW; Kühl HP
    J Magn Reson Imaging; 2007 Jun; 25(6):1283-7. PubMed ID: 17520735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
    Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
    J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to Letters Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis".
    Fontana M; Pica S; Reant P; Abdel-Gadir A; Treibel TA; Banypersad SM; Maestrini V; Barcella W; Rosmini S; Bulluck H; Sayed RH; Patel K; Mamhood S; Bucciarelli-Ducci C; Whelan CJ; Herrey AS; Lachmann HJ; Wechalekar AD; Manisty CH; Schelbert EB; Kellman P; Gillmore JD; Hawkins PN; Moon JC
    Circulation; 2016 Mar; 133(12):e450-1. PubMed ID: 27002091
    [No Abstract]   [Full Text] [Related]  

  • 25. Value of classical criteria for diagnosis of cardiac amyloidosis re-evaluated with magnetic resonance.
    Pozo E; Sanz J
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1133-6. PubMed ID: 25205232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
    Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
    Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unusual case of cardiac amyloidosis.
    Bucciarelli-Ducci C; Pennell DJ
    J Gen Intern Med; 2007 Sep; 22(9):1382. PubMed ID: 17632762
    [No Abstract]   [Full Text] [Related]  

  • 28. [Abnormal gadolinium kinetics in cardio MRI - always an indication of cardiac amyloidosis?].
    Baeßler B; Reuter H; Huntgeburth M; Bunck AC
    Rofo; 2015 Mar; 187(3):189-91. PubMed ID: 25184217
    [No Abstract]   [Full Text] [Related]  

  • 29. [Dypsnea in a patient with liver transplant].
    Escobar C; Echarri R; Calderón A; Barrios V
    Rev Clin Esp; 2007 Oct; 207(9):469-70. PubMed ID: 17915171
    [No Abstract]   [Full Text] [Related]  

  • 30. Edema and heart failure without cardiomegaly.
    Cody RJ
    Hosp Pract (Hosp Ed); 1982 May; 17(5):65-6, 70. PubMed ID: 7200954
    [No Abstract]   [Full Text] [Related]  

  • 31. Developing imaging biomarkers for myocardial involvement in amyloidosis: challenge and opportunity.
    Udelson JE
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):60-62. PubMed ID: 25592696
    [No Abstract]   [Full Text] [Related]  

  • 32. The evolving role of cardiovascular magnetic resonance imaging in nonischemic cardiomyopathy.
    Isbell DC; Kramer CM
    Semin Ultrasound CT MR; 2006 Feb; 27(1):20-31. PubMed ID: 16562569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac amyloidosis: non-invasive diagnosis and current treatment strategies.
    Lodge FM; Dubrey SW; Collinson J; Prasad SK
    Br J Hosp Med (Lond); 2010 Apr; 71(4):230-1. PubMed ID: 20393437
    [No Abstract]   [Full Text] [Related]  

  • 34. [Stress dyspnea in a 56-year-old man].
    Blumenstein M; Burkhardt R; Hübner G; Schultheiss HP; Strauer BE
    Internist (Berl); 1985 Nov; 26(11):701-5. PubMed ID: 3908376
    [No Abstract]   [Full Text] [Related]  

  • 35. MR Imaging and Cardiac Amyloidosis Where to Go From Here?
    Selvanayagam JB; Leong DP
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):165-7. PubMed ID: 20159643
    [No Abstract]   [Full Text] [Related]  

  • 36. High risk, low volume: a young female patient complaining of fatigue.
    Gilboy N
    J Emerg Nurs; 2008 Dec; 34(6):589-90. PubMed ID: 19022097
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cardiac amyloidosis].
    Hoyer C; Angermann CE; Knop S; Ertl G; Störk S
    Med Klin (Munich); 2008 Mar; 103(3):153-60. PubMed ID: 18344065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac amyloidosis: a practical approach to diagnosis and management.
    Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
    Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac diphosphonate uptake.
    Noordzij W; Glaudemans AW; Slart RH; Hazenberg BP
    Heart; 2014 Aug; 100(15):1192, 1217. PubMed ID: 24548918
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.